Use and cost of polypharmacy in schizophrenia: Data from a randomized, double-blind study of risperidone and quetiapine

被引：0
|
作者：
Stahl, S [1 ]
Rupnow, M [1 ]
Greenspan, A [1 ]
Kosik-Gonzalez, C [1 ]
Zhu, Y [1 ]
Gharabawi, G [1 ]
机构：
[1] Neurosci Educ Inst, Carlsbad, CA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2004年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] Use and cost of polypharmacy in schizophrenia: Data from a randomized, double-blind study of risperidone and quetiapine
    Rupnow, MF
    Greenspan, A
    Kosik-Gonzalez, C
    Zhu, Y
    Gharabawi, G
    Stahl, SM
    VALUE IN HEALTH, 2005, 8 (03) : 399 - 399
  • [2] Use and cost of polypharmacy in schizophrenia: Data from a randomized, double-blind study of risperidone and quetiapine
    Rupnow, MF
    Stahl, S
    Greenspan, A
    Kosik-Gonzalez, C
    Gharabawi, G
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 550 - 550
  • [3] A randomized, double-blind study of quetiapine and risperidone in the treatment of schizophrenia
    Zhong, K
    Harvey, P
    Brecher, M
    Sweitzer, D
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S232 - S232
  • [4] A randomized double-blind study of quetiapine and risperidone in the treatment of schizophrenia
    Zhong, K
    Harvey, P
    Brecher, M
    Sweitzer, D
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 508 - 508
  • [5] Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder
    Rupnow, Marcia F. T.
    Greenspan, Andrew
    Gharabawi, Georges M.
    Kosik-Gonzalez, Colette
    Zhu, Young
    Stahl, Stephen M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2815 - 2822
  • [6] Olanzapine and risperidone in schizophrenia: A randomized double-blind crossover study
    Irwin, J
    Moses, SN
    Edgar, JC
    Torres, F
    Thoma, RJ
    Hanlon, FM
    Anderson, L
    Weisend, MP
    Miller, GA
    Tuason, VB
    Canive, JM
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 286 - 286
  • [7] A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia
    Kelly, DL
    Conley, RR
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (03) : 340 - 346
  • [8] Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
    Zhong, Kate X.
    Sweitzer, Dennis E.
    Hamer, Robert M.
    Lieberman, Jeffrey A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (07) : 1093 - 1103
  • [9] Risperidone vs. quetiapine in inpatients with schizophrenia: a double-blind placebo-controlled study
    Greenspan, A
    Kosik-Gonzalez, C
    Moreau-Matlet, V
    Bossie, CA
    Rupnow, MFT
    Zhu, Y
    Gharabawi, GM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S503 - S504
  • [10] A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia
    Gharabawi, Georges M.
    Bossie, Cynthia A.
    Pandina, Gahan J.
    Kujawa, Mary J.
    Greenspan, Andrew J.
    Zhu, Young
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 333 - 333
12345